IL-17 and insulin/IGF1 enhance adhesion of prostate cancer cells to vascular endothelial cells through CD44-VCAM-1 interaction

Prostate

Volumn 75, Issue 8, 2015, Pages 883-895

  Chen, Chong ^a   Zhang, Qiuyang ^a   Liu, Sen ^a   Parajuli, Keshab R ^a   Qu, Yine ^a,b   Mei, Jiandong ^a,c   Chen, Zhiquan ^a,b   Zhang, Hui ^a,d   Khismatullin, Damir B ^a,e   You, Zongbing ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HEBEI UNITED UNIVERSITY   (China)

^c SICHUAN UNIVERSITY   (China)

^d SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

^e TULANE UNIVERSITY   (United States)

Author keywords

IGF1; IL 17; insulin; prostate cancer metastasis; VCAM 1

Indexed keywords

ALPHA4 INTEGRIN; BETA1 INTEGRIN; HERMES ANTIGEN; INSULIN; INTERLEUKIN 17; SOMATOMEDIN C; VASCULAR CELL ADHESION MOLECULE 1; CD44 PROTEIN, HUMAN; IGF1 PROTEIN, HUMAN;

ARTICLE; CELL ADHESION; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LNCAP CELL LINE; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE CANCER CELL LINE; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING; DRUG EFFECTS; ENDOTHELIUM CELL; METABOLISM; PHYSIOLOGY; PROSTATE TUMOR; TUMOR CELL LINE;

ANTIGENS, CD44; CELL ADHESION; CELL LINE, TUMOR; ENDOTHELIAL CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; INTERLEUKIN-17; MALE; PROSTATIC NEOPLASMS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84927909975     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.22971     Document Type: Article

References (50)

1. Entschladen F, Drell TLt, Lang K, Joseph J, Zaenker KS,. Tumour-cell migration, invasion, and metastasis: Navigation by neurotransmitters. Lancet Oncol 2004; 5 (4): 254-258.
2. Orr FW, Wang HH, Lafrenie RM, Scherbarth S, Nance DM,. Interactions between cancer cells and the endothelium in metastasis. J Pathol 2000; 190 (3): 310-329.
3. Wong SY, Hynes RO,. Lymphatic or hematogenous dissemination: How does a metastatic tumor cell decide. Cell Cycle 2006; 5 (8): 812-817.
4. Miles FL, Pruitt FL, van Golen KL, Cooper CR,. Stepping out of the flow: Capillary extravasation in cancer metastasis. Clin Exp Metastasis 2008; 25 (4): 305-324.
5. Fidler IJ,. The pathogenesis of cancer metastasis: The 'seed and soil' hypothesis revisited. Nat Rev Cancer 2003; 3 (6): 453-458.
6. Scherbarth S, Orr FW,. Intravital videomicroscopic evidence for regulation of metastasis by the hepatic microvasculature: Effects of interleukin-1alpha on metastasis and the location of B16F1 melanoma cell arrest. Cancer Res 1997; 57 (18): 4105-4110.
7. Huh SJ, Liang S, Sharma A, Dong C, Robertson GP,. Transiently entrapped circulating tumor cells interact with neutrophils to facilitate lung metastasis development. Cancer Res 2010; 70 (14): 6071-6082.
8. Auguste P, Fallavollita L, Wang N, Burnier J, Bikfalvi A, Brodt P,. The host inflammatory response promotes liver metastasis by increasing tumor cell arrest and extravasation. Am J Pathol 2007; 170 (5): 1781-1792.
9. Matsuura N, Puzon-McLaughlin W, Irie A, Morikawa Y, Kakudo K, Takada Y,. Induction of experimental bone metastasis in mice by transfection of integrin alpha 4 beta 1 into tumor cells. Am J Pathol 1996; 148 (1): 55-61.
10. Kolls JK, Linden A,. Interleukin-17 family members and inflammation. Immunity 2004; 21 (4): 467-476.
11. Novatchkova M, Leibbrandt A, Werzowa J, Neubuser A, Eisenhaber F,. The STIR-domain superfamily in signal transduction, development and immunity. Trends Biochem Sci 2003; 28 (5): 226-229.
12. Chang SH, Park H, Dong C,. Act1 adaptor protein is an immediate and essential signaling component of interleukin-17 receptor. J Biol Chem 2006; 281 (47): 35603-35607.
13. Qian Y, Liu C, Hartupee J, Altuntas CZ, Gulen MF, Jane-Wit D, Xiao J, Lu Y, Giltiay N, Liu J, Kordula T, Zhang QW, Vallance B, Swaidani S, Aronica M, Tuohy VK, Hamilton T, Li X,. The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease. Nat Immunol 2007; 8 (3): 247-256.
14. Maitra A, Shen F, Hanel W, Mossman K, Tocker J, Swart D, Gaffen SL,. Distinct functional motifs within the IL-17 receptor regulate signal transduction and target gene expression. Proc Natl Acad Sci U S A 2007; 104 (18): 7506-7511.
15. Ho AW, Shen F, Conti HR, Patel N, Childs EE, Peterson AC, Hernandez-Santos N, Kolls JK, Kane LP, Ouyang W, Gaffen SL,. IL-17RC is required for immune signaling via an extended SEF/IL-17R signaling domain in the cytoplasmic tail. J Immunol 2010; 185 (2): 1063-1070.
16. Liu C, Qian W, Qian Y, Giltiay NV, Lu Y, Swaidani S, Misra S, Deng L, Chen ZJ, Li X,. Act1, a U-box E3 ubiquitin ligase for IL-17 signaling. Sci Signal 2009; 2 (92): 63.
17. Ge D, Dauchy RT, Liu S, Zhang Q, Mao L, Dauchy EM, Blask DE, Hill SM, Rowan BG, Brainard GC, Hanifin JP, Cecil KS, Xiong Z, Myers L, You Z,. Insulin and IGF1 enhance IL-17-induced chemokine expression through a GSK3B-dependent mechanism: a new target for melatonin's anti-inflammatory action. J Pineal Res 2013; 55 (4): 377-387.
18. Zhu S, Pan W, Song X, Liu Y, Shao X, Tang Y, Liang D, He D, Wang H, Liu W, Shi Y, Harley JB, Shen N, Qian Y,. The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-alpha. Nat Med 2012; 18 (7): 1077-1086.
19. Hwang SY, Kim JY, Kim KW, Park MK, Moon Y, Kim WU, Kim HY,. IL-17 induces production of IL-6 and IL-8 in rheumatoid arthritis synovial fibroblasts via NF-kappaB- and PI3-kinase/Akt-dependent pathways. Arthritis Res Ther 2004; 6 (2): R120-R128.
20. Zhang Q, Liu S, Ge D, Xue Y, Xiong Z, Abdel-Mageed AB, Myers L, Hill SM, Rowan BG, Sartor O, Melamed J, Chen Z, You Z,. Interleukin-17 promotes formation and growth of prostate adenocarcinoma in mouse models. Cancer Res 2012; 72 (10): 2589-2599.
21. Zhang Q, Liu S, Xiong Z, Wang AR, Myers L, Melamed J, Tang WW, You Z,. Interleukin-17 promotes development of castration-resistant prostate cancer potentially through creating an immunotolerant and pro-angiogenic tumor microenvironment. Prostate 2014; 74 (8): 869-879.
22. Baxter RC, Bryson JM, Turtle JR,. Somatogenic receptors of rat liver: regulation by insulin. Endocrinology 1980; 107 (4): 1176-1181.
23. Madonna R, Pandolfi A, Massaro M, Consoli A, De Caterina R,. Insulin enhances vascular cell adhesion molecule-1 expression in human cultured endothelial cells through a pro-atherogenic pathway mediated by p38 mitogen-activated protein-kinase. Diabetologia 2004; 47 (3): 532-536.
24. Balaram SK, Agrawal DK, Allen RT, Kuszynski CA, Edwards JD,. Cell adhesion molecules and insulin-like growth factor-1 in vascular disease. J Vasc Surg 1997; 25 (5): 866-876.
25. Roussel L, Houle F, Chan C, Yao Y, Berube J, Olivenstein R, Martin JG, Huot J, Hamid Q, Ferri L, Rousseau S,. IL-17 promotes p38 MAPK-dependent endothelial activation enhancing neutrophil recruitment to sites of inflammation. J Immunol 2010; 184 (8): 4531-4537.
26. Xing X, Yang J, Yang X, Wei Y, Zhu L, Gao D, Li M,. IL-17A induces endothelial inflammation in systemic sclerosis via the ERK signaling pathway. PLoS ONE 2013; 8 (12):- e85032.
27. Mackesy DZ, Goalstone ML,. Insulin augments tumor necrosis factor-alpha stimulated expression of vascular cell adhesion molecule-1 in vascular endothelial cells. J Inflamm (Lond) 2011; 8: 34.
28. Klockenbusch C, Kast J,. Optimization of formaldehyde cross-linking for protein interaction analysis of non-tagged integrin beta1. J Biomed Biotechnol 2010; 2010: 927585.
29. Wang PC, Weng CC, Hou YS, Jian SF, Fang KT, Hou MF, Cheng KH,. Activation of VCAM-1 and its associated molecule CD44 leads to increased malignant potential of breast cancer cells. Int J Mol Sci 2014; 15 (3): 3560-3579.
30. Chen CC, Rosenbloom CL, Anderson DC, Manning AM,. Selective inhibition of E-selectin, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 expression by inhibitors of I kappa B-alpha phosphorylation. J Immunol 1995; 155 (7): 3538-3545.
31. Montes-Sanchez D, Ventura JL, Mitre I, Frias S, Michan L, Espejel-Nunez A, Vadillo-Ortega F, Zentella A,. Glycosylated VCAM-1 isoforms revealed in 2D western blots of HUVECs treated with tumoral soluble factors of breast cancer cells. BMC Chem Biol 2009; 9: 7.
32. Ruddy MJ, Wong GC, Liu XK, Yamamoto H, Kasayama S, Kirkwood KL, Gaffen SL,. Functional cooperation between interleukin-17 and tumor necrosis factor-alpha is mediated by CCAAT/enhancer-binding protein family members. J Biol Chem 2004; 279 (4): 2559-2567.
33. Chen C, Zhang Q, Liu S, Lambrechts M, Qu Y, You Z,. AZD5363 Inhibits Inflammatory Synergy between Interleukin-17 and Insulin/Insulin-Like Growth Factor 1. Front Oncol 2014; 4: 343.
34. Shen F, Li N, Gade P, Kalvakolanu DV, Weibley T, Doble B, Woodgett JR, Wood TD, Gaffen SL,. IL-17 receptor signaling inhibits C/EBPbeta by sequential phosphorylation of the regulatory 2 domain. Sci Signal 2009; 2 (59): ra8.
35. Galkina E, Ley K,. Immune and inflammatory mechanisms of atherosclerosis. Annu Rev Immunol 2009; 27: 165-197.
36. Alon R, Kassner PD, Carr MW, Finger EB, Hemler ME, Springer TA,. The integrin VLA-4 supports tethering and rolling in flow on VCAM-1. J Cell Biol 1995; 128 (6): 1243-1253.
37. Goodison S, Urquidi V, Tarin D,. CD44 cell adhesion molecules. Mol Pathol 1999; 52 (4): 189-196.
38. Mohamadzadeh M, DeGrendele H, Arizpe H, Estess P, Siegelman M,. Proinflammatory stimuli regulate endothelial hyaluronan expression and CD44/HA-dependent primary adhesion. J Clin Invest 1998; 101 (1): 97-108.
39. Thomas SN, Zhu F, Schnaar RL, Alves CS, Konstantopoulos K,. Carcinoembryonic antigen and CD44 variant isoforms cooperate to mediate colon carcinoma cell adhesion to E- and L-selectin in shear flow. J Biol Chem 2008; 283 (23): 15647-15655.
40. Dimitroff CJ, Lee JY, Rafii S, Fuhlbrigge RC, Sackstein R,. CD44 is a major E-selectin ligand on human hematopoietic progenitor cells. J Cell Biol 2001; 153 (6): 1277-1286.
41. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF,. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 2003; 100 (7): 3983-3988.
42. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ,. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 2005; 65 (23): 10946-10951.
43. Patrawala L, Calhoun T, Schneider-Broussard R, Li H, Bhatia B, Tang S, Reilly JG, Chandra D, Zhou J, Claypool K, Coghlan L, Tang DG,. Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene 2006; 25 (12): 1696-1708.
44. Hurt EM, Kawasaki BT, Klarmann GJ, Thomas SB, Farrar WL,. CD44+ CD24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis. Br J Cancer 2008; 98 (4): 756-765.
45. Draffin JE, McFarlane S, Hill A, Johnston PG, Waugh DJ,. CD44 potentiates the adherence of metastatic prostate and breast cancer cells to bone marrow endothelial cells. Cancer Res 2004; 64 (16): 5702-5711.
46. Liu C, Kelnar K, Liu B, Chen X, Calhoun-Davis T, Li H, Patrawala L, Yan H, Jeter C, Honorio S, Wiggins JF, Bader AG, Fagin R, Brown D, Tang DG,. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat Med 2011; 17 (2): 211-215.
47. Gong Z, Agalliu I, Lin DW, Stanford JL, Kristal AR,. Obesity is associated with increased risks of prostate cancer metastasis and death after initial cancer diagnosis in middle-aged men. Cancer 2007; 109 (6): 1192-1202.
48. Keto CJ, Aronson WJ, Terris MK, Presti JC, Kane CJ, Amling CL, Freedland SJ,. Obesity is associated with castration-resistant disease and metastasis in men treated with androgen deprivation therapy after radical prostatectomy: Results from the SEARCH database. BJU Int 2012; 110 (4): 492-498.
49. Cohen DH, LeRoith D,. Obesity, type 2 diabetes, and cancer: The insulin and IGF connection. Endocr Relat Cancer 2012; 19 (5): F27-F45.
50. Sumarac-Dumanovic M, Stevanovic D, Ljubic A, Jorga J, Simic M, Stamenkovic-Pejkovic D, Starcevic V, Trajkovic V, Micic D,. Increased activity of interleukin-23/interleukin-17 proinflammatory axis in obese women. Int J Obes (Lond) 2009; 33 (1): 151-156.